Clinical Trial Update: Enhancing PrEP Uptake and Retention Among Latine TGW and GBM in the South Using Long-Acting Injectable PrEP [Phase 4]

View source ↗

Summary

A Phase 4 trial update focusing on boosting uptake and retention of long-acting injectable PrEP among Latine transgender women and gay/bisexual men in the U.S. …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• APRETUDE (CABOTEGRAVIR)

Snippet

Sponsor: Duke University | Conditions: HIV Prevention, HIV Pre-exposure Prophylaxis | Phase 4 | Status: RECRUITING